Literature DB >> 18820381

The newborn with seizures -- a follow-up study.

Mary Iype1, Maya Prasad, P M C Nair, S Geetha, Lalitha Kailas.   

Abstract

OBJECTIVE: To determine the sequelae of neonatal seizures in a cohort of newborns, recruited over a six month period.
DESIGN: Prospective hospital based study.
SETTING: The neonatal intensive care unit (NICU) of a tertiary care hospital. PARTICIPANTS: 135 babies were recruited of whom 10 died and 25 were lost to follow up.
METHODS: The cases were followed up over four months.
RESULTS: 68% of the babies followed up were normal; 32% had an abnormal neurological outcome. Seven (7%) developed post-neonatal epilepsy. Hypocalcemia was significantly associated with mortality (OR: 21.9; 95% CI: 1.2-391.2). No risk factors could be identified for post neonatal epilepsy. Presence of spike waves in the EEG was significantly related to abnormal neurological outcome (OR: 3.5; 95% C.I. 1.2-10.8).
CONCLUSIONS: Majority of neonates with seizures have a normal outcome with no developmental delay or neurological deficit. Predominantly spike waves in the EEG is predictive of abnormal neurological outcome.

Entities:  

Mesh:

Year:  2008        PMID: 18820381

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  4 in total

Review 1.  Recent advances in neonatal seizures.

Authors:  Sujata Kanhere
Journal:  Indian J Pediatr       Date:  2014-08-16       Impact factor: 1.967

2.  Management of neonatal seizures.

Authors:  Jeeva M Sankar; Ramesh Agarwal; Ashok Deorari; Vinod K Paul
Journal:  Indian J Pediatr       Date:  2010-09-30       Impact factor: 1.967

3.  Etiology, Clinical Features, And Short-Term Outcome Of Seizures In Newborns Admitted To The University Of Gondar Hospital, Ethiopia.

Authors:  Hailu Tazebew Amare; Ashenafi Tazebew Amare
Journal:  Pediatric Health Med Ther       Date:  2019-10-18

4.  Assessment of Preterm Infants Using the Bayley-III Scales in Korea.

Authors:  Sung Ho Ahn; Soo A Kim
Journal:  Ann Rehabil Med       Date:  2017-10-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.